Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women

Pierre D. Delmas, Nina H. Bjarnason, Bruce Mitlak, Anne-Catherine Ravoux, Aarti S. Shah, William J. Huster, Michael Draper, Claus Christiansen

New England Journal of Medicine · 1997 · 1.6K citations · 30 references

DOIFull text

Open access

Abstract

Daily therapy with raloxifene increases bone mineral density, lowers serum concentrations of total and low-density lipoprotein cholesterol, and does not stimulate the endometrium.

References

30